These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 9150116)

  • 1. The use of autologous transplantation in the treatment of malignant disorders.
    Territo M
    J Rheumatol Suppl; 1997 May; 48():36-40. PubMed ID: 9150116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [High-dose chemotherapy with autologous bone marrow transplantation: 11 years' experience in Zurich].
    Jost LM; Honegger HP; Stahel RA
    Schweiz Med Wochenschr; 2000 Jan; 130(3):60-9. PubMed ID: 10683881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High-dose therapy and hematopoietic cell autotransplantation in the treatment of adult gynecologic tumors].
    Lotz JP; Pene F; Bouleuc C; André T; Gligorov J; Avenin D; Esteso A; Bellaiche A; Macovei C; Merad Z; Laadem A; Vanica R; Izrael V
    Contracept Fertil Sex; 1996 Apr; 24(4):307-18. PubMed ID: 8704806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
    Weisdorf D; Miller J; Verfaillie C; Burns L; Wagner J; Blazar B; Davies S; Miller W; Hannan P; Steinbuch M; Ramsay N; McGlave P
    Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hematopoietic stem cell transplantation].
    Kohgo Y; Sakamaki S; Hirayama Y; Matsunaga T; Niitsu Y
    Hokkaido Igaku Zasshi; 1995 Mar; 70(2):241-5. PubMed ID: 7774876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous bone marrow support and bone disease in metastatic breast cancer.
    Nabholtz JM; al-Tweigeri T; Jacquelin N; Venner PM
    Can J Oncol; 1995 Dec; 5 Suppl 1():33-9. PubMed ID: 8853522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.
    Durando X; Lemaire JJ; Tortochaux J; Van-Praagh I; Kwiatkowski F; Vincent C; Bailly C; Verrelle P; Irthum B; Chazal J; Bay JO
    Bone Marrow Transplant; 2003 Apr; 31(7):559-64. PubMed ID: 12692621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term haematological recovery following high-dose chemotherapy with autologous bone marrow transplantation or peripheral stem cell transplantation in patients with solid tumours.
    Nieboer P; de Vries EG; Mulder NH; Sleijfer DT; Willemse PH; Hospers GA; Gietema JA; Sluiter WJ; van Der Graaf WT
    Bone Marrow Transplant; 2001 May; 27(9):959-66. PubMed ID: 11436106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
    Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
    Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose chemotherapy with stem cell reinfusion and growth factor support for solid tumors.
    de Vries EG; de Graaf H; Boonstra A; van der Graaf WT; Mulder NH
    Stem Cells; 1995 Nov; 13(6):597-606. PubMed ID: 8590861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous hematopoietic stem cell transplantation for pediatric solid tumors.
    Hale GA
    Expert Rev Anticancer Ther; 2005 Oct; 5(5):835-46. PubMed ID: 16221053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
    J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of tumor contamination in the bone marrow from high-risk primary breast cancer patients treated with high-dose chemotherapy and hematopoietic support.
    Vredenburgh JJ; Silva O; Broadwater G; Berry D; DeSombre K; Tyer C; Petros WP; Peters WP; Bast RC
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):91-7. PubMed ID: 9267669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response.
    Ganguly S; Divine CL; Deauna-Limayo D; Bodensteiner DC; Cook JD; Lewis JN; Skikne BS
    Ann Hematol; 2005 Aug; 84(8):526-31. PubMed ID: 15915350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose chemotherapy and autologous transplant with peripheral-blood stem cells.
    Vose JM; Armitage JO; Kessinger A
    Oncology (Williston Park); 1993 Aug; 7(8):23-9; discussion 29-30, 33-4. PubMed ID: 8104456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Single and double high-dose chemotherapy with autologous stem cell transplantation in children with advanced solid tumors: first experiences].
    Kühne T; Staehelin F; Avoledo P; Tichelli A; Passweg J; Imbach P; Gratwohl A
    Schweiz Med Wochenschr; 2000 Mar; 130(12):419-25. PubMed ID: 10780056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
    Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
    Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult tumor cells detected in autologous blood stem cell harvests have no impact on 5 year outcomes for breast cancer patients with 4-9 positive nodes treated with adjuvant high-dose therapy and stem cell transplantation.
    Reed E; Kessinger A; Murphy B; Tarantolo S; Traystman M; Sharp JG
    Bone Marrow Transplant; 2003 Apr; 31(7):571-4. PubMed ID: 12692623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.